Global Topical Drug Delivery Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
Global topical drug delivery market is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a CAGR of 9.2% in the forecast period 2017 to 2024.
Based on geography, the global topical drug delivery market is segmented into 5 geographical regions, such as,
North America,
South America,
Europe,
APAC,
MEA.
Global topical drug delivery market competition by top players including –
Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals. Some of the other players in the global topical drug delivery market are
MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company),
Crescita Therapeutics,
West Pharmaceutical Services,
Biofarmitalia s.r.l,
Pharmatek Laboratories, Inc.,
Stiefel Laboratories, Inc.,
Tapemark, Acrux Limited,
Nitto Denko Corporation,
Skinvisible Pharmaceuticals, Inc.,
Mylan Pharmaceuticals Inc.,
Pocono Coated Products LLC,
TheraSolve NV.,
Samyang Biopharmaceuticals Corporation,
Lohmann Therapie-Systeme AG,
Prosollus Pharmaceuticals,
Easton Pharmaceuticals Inc.,
Novosis AG,
Endo Pharmaceuticals Inc.,
Transdermal Technologies, Inc.,
Sheffield Pharmaceuticals, Inc.,
Solvay
The global topical drug delivery market is segmented on the basis of product type, indication, distribution channel, end user and geography.
On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations.
Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories.
The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.
The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others.
On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.
Based on geography, the global topical drug delivery market is segmented into 5 geographical regions, such as,
North America,
South America,
Europe,
APAC,
MEA.
Global topical drug delivery market competition by top players including –
Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals. Some of the other players in the global topical drug delivery market are
MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company),
Crescita Therapeutics,
West Pharmaceutical Services,
Biofarmitalia s.r.l,
Pharmatek Laboratories, Inc.,
Stiefel Laboratories, Inc.,
Tapemark, Acrux Limited,
Nitto Denko Corporation,
Skinvisible Pharmaceuticals, Inc.,
Mylan Pharmaceuticals Inc.,
Pocono Coated Products LLC,
TheraSolve NV.,
Samyang Biopharmaceuticals Corporation,
Lohmann Therapie-Systeme AG,
Prosollus Pharmaceuticals,
Easton Pharmaceuticals Inc.,
Novosis AG,
Endo Pharmaceuticals Inc.,
Transdermal Technologies, Inc.,
Sheffield Pharmaceuticals, Inc.,
Solvay
The global topical drug delivery market is segmented on the basis of product type, indication, distribution channel, end user and geography.
On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations.
Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories.
The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.
The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others.
On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.
1. INTRODUCTION
1.1. OVERVIEW OF GLOBAL TOPICAL DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF ACUTE AND CHRONIC DISEASE
3.1.2. RISING AGING POPULATION
3.1.3. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
3.1.4. APPROVAL OF NEW DRUGS
3.1.5. BETTER OPPORTUNITY IN PHARMERGING MARKETS
3.2. RESTRAINTS
3.2.1. REGULATORY SCENARIO AND PRICING PRESSURE
3.3. OPPORTUNITY
3.3.1. ENERGING MARKET
3.3.2. RISING ACCEPTANCE FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. PRODUCT RECALL
3.4.2. PENETRATION INTO THE SMALLER MARKETS
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE
6.1. OVERVIEW
6.2. TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
6.3. TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.4. LIQUID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.5. SEMI SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.6. SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
7. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.1. OVERVIEW
7.2. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.3. GLOBAL ANTI-INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
8. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END USER
9.1. OVERVIEW
10. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET
10.2.1. U.S. TOPICAL DRUG DELIVERY MARKET
10.2.2. CANADA TOPICAL DRUG DELIVERY MARKET
10.2.3. MEXICO TOPICAL DRUG DELIVERY MARKET
10.3. EUROPE TOPICAL DRUG DELIVERY MARKET
10.3.1. GERMANY TOPICAL DRUG DELIVERY MARKET
10.3.2. FRANCE TOPICAL DRUG DELIVERY MARKET
10.3.3. ITALY TOPICAL DRUG DELIVERY MARKET
10.3.4. U.K. TOPICAL DRUG DELIVERY MARKET
10.3.5. SWITZERLAND TOPICAL DRUG DELIVERY MARKET
10.3.6. SPAIN TOPICAL DRUG DELIVERY MARKET
10.3.7. NETHERLAND TOPICAL DRUG DELIVERY MARKET
10.3.8. RUSSIA TOPICAL DRUG DELIVERY MARKET
10.3.9. TURKEY TOPICAL DRUG DELIVERY MARKET
10.3.10. BELGIUM TOPICAL DRUG DELIVERY MARKET
10.3.11. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET
10.4. APAC TOPICAL DRUG DELIVERY MARKET
10.4.1. JAPAN TOPICAL DRUG DELIVERY MARKET
10.4.2. CHINA TOPICAL DRUG DELIVERY MARKET
10.4.3. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET
10.4.4. INDIA TOPICAL DRUG DELIVERY MARKET
10.4.5. AUSTRALIA TOPICAL DRUG DELIVERY MARKET
10.4.6. SINGAPORE TOPICAL DRUG DELIVERY MARKET
10.4.7. THAILAND TOPICAL DRUG DELIVERY MARKET
10.4.8. MALAYSIA TOPICAL DRUG DELIVERY MARKET
10.4.9. INDONESIA TOPICAL DRUG DELIVERY MARKET
10.4.10. PHILIPPINES TOPICAL DRUG DELIVERY MARKET
10.4.11. REST OF APAC TOPICAL DRUG DELIVERY MARKET
10.5. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET
10.5.1. BRAZIL TOPICAL DRUG DELIVERY MARKET
10.5.2. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET
10.6. MIDDLE EAST AND AFRICA (MEA) TOPICAL DRUG DELIVERY MARKET
10.6.1. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET
10.6.2. REST OF MEA TOPICAL DRUG DELIVERY MARKET
11. GLOBAL TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: GLOBAL
12. COMPANY PROFILES
12.1. GALDERMA PHARMA S.A.
12.1.1. COMPANY OVERVIEW
12.1.2. FINANCIAL OVERVIEW
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. HISAMITSU PHARMACEUTICAL CO., INC.
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. PFIZER INC.
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS
12.4. ABBVIE INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS
12.5. BAYER AG
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6. 3M
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7. ANTARES PHARMA, INC.
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.9. ALLERGAN PLC.
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
12.10. KAKEN PHARMACEUTICALS CO., LTD
12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
13. RELATED REPORTS
1.1. OVERVIEW OF GLOBAL TOPICAL DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF ACUTE AND CHRONIC DISEASE
3.1.2. RISING AGING POPULATION
3.1.3. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
3.1.4. APPROVAL OF NEW DRUGS
3.1.5. BETTER OPPORTUNITY IN PHARMERGING MARKETS
3.2. RESTRAINTS
3.2.1. REGULATORY SCENARIO AND PRICING PRESSURE
3.3. OPPORTUNITY
3.3.1. ENERGING MARKET
3.3.2. RISING ACCEPTANCE FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. PRODUCT RECALL
3.4.2. PENETRATION INTO THE SMALLER MARKETS
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE
6.1. OVERVIEW
6.2. TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
6.3. TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.4. LIQUID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.5. SEMI SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.6. SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
7. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.1. OVERVIEW
7.2. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.3. GLOBAL ANTI-INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
8. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END USER
9.1. OVERVIEW
10. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET
10.2.1. U.S. TOPICAL DRUG DELIVERY MARKET
10.2.2. CANADA TOPICAL DRUG DELIVERY MARKET
10.2.3. MEXICO TOPICAL DRUG DELIVERY MARKET
10.3. EUROPE TOPICAL DRUG DELIVERY MARKET
10.3.1. GERMANY TOPICAL DRUG DELIVERY MARKET
10.3.2. FRANCE TOPICAL DRUG DELIVERY MARKET
10.3.3. ITALY TOPICAL DRUG DELIVERY MARKET
10.3.4. U.K. TOPICAL DRUG DELIVERY MARKET
10.3.5. SWITZERLAND TOPICAL DRUG DELIVERY MARKET
10.3.6. SPAIN TOPICAL DRUG DELIVERY MARKET
10.3.7. NETHERLAND TOPICAL DRUG DELIVERY MARKET
10.3.8. RUSSIA TOPICAL DRUG DELIVERY MARKET
10.3.9. TURKEY TOPICAL DRUG DELIVERY MARKET
10.3.10. BELGIUM TOPICAL DRUG DELIVERY MARKET
10.3.11. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET
10.4. APAC TOPICAL DRUG DELIVERY MARKET
10.4.1. JAPAN TOPICAL DRUG DELIVERY MARKET
10.4.2. CHINA TOPICAL DRUG DELIVERY MARKET
10.4.3. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET
10.4.4. INDIA TOPICAL DRUG DELIVERY MARKET
10.4.5. AUSTRALIA TOPICAL DRUG DELIVERY MARKET
10.4.6. SINGAPORE TOPICAL DRUG DELIVERY MARKET
10.4.7. THAILAND TOPICAL DRUG DELIVERY MARKET
10.4.8. MALAYSIA TOPICAL DRUG DELIVERY MARKET
10.4.9. INDONESIA TOPICAL DRUG DELIVERY MARKET
10.4.10. PHILIPPINES TOPICAL DRUG DELIVERY MARKET
10.4.11. REST OF APAC TOPICAL DRUG DELIVERY MARKET
10.5. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET
10.5.1. BRAZIL TOPICAL DRUG DELIVERY MARKET
10.5.2. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET
10.6. MIDDLE EAST AND AFRICA (MEA) TOPICAL DRUG DELIVERY MARKET
10.6.1. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET
10.6.2. REST OF MEA TOPICAL DRUG DELIVERY MARKET
11. GLOBAL TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: GLOBAL
12. COMPANY PROFILES
12.1. GALDERMA PHARMA S.A.
12.1.1. COMPANY OVERVIEW
12.1.2. FINANCIAL OVERVIEW
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. HISAMITSU PHARMACEUTICAL CO., INC.
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. PFIZER INC.
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS
12.4. ABBVIE INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS
12.5. BAYER AG
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6. 3M
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7. ANTARES PHARMA, INC.
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.9. ALLERGAN PLC.
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
12.10. KAKEN PHARMACEUTICALS CO., LTD
12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
13. RELATED REPORTS
LIST OF TABLES
Table 1 LIST OF APPROVED TOPICAL DRUGS
Table 2 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
Table 3 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 4 GLOBAL TDDF MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 5 GLOBAL LIQUID TDDF MARKET, BY PRODUCT TYPE, 2015– 2024(USD BILLION)
Table 6 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015– 2024 (USD BILLION)
Table 7 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015– 2024 (USD BILLION)
Table 8 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
Table 9 GLOBAL ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2014 – 2024 (USD BILLION)
Table 10 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
Table 11 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD BILLION)
Table 12 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY, 2015 – 2024 (USD BILLION)
Table 13 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION)
Table 14 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD BILLION)
Table 15 NORTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 16 NORTH AMERICA TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
Table 17 NORTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
Table 18 NORTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
Table 19 NORTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD BILLION)
Table 20 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
Table 21 NORTH AMERICA ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015– 2024 (USD BILLION)
Table 22 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD BILLION)
Table 23 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD BILLION)
Table 24 U.S. TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION)
Table 25 U.S. TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 26 U.S. TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 27 U.S.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 28 U.S.LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
Table 29 U.S.SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 30 U.S. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 31 U.S. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 32 CANADA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION)
Table 33 CANADA TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 34 CANADA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 35 CANADA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 36 CANADALIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
Table 37 CANADASOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 38 CANADA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 39 CANADA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 40 MEXICO TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION)
Table 41 MEXICO TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 42 MEXICO TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 43 MEXICOSEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 44 MEXICOLIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
Table 45 MEXICOSOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 46 MEXICO TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 47 MEXICO TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 48 EUROPE TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION)
Table 49 EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 50 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 51 EUROPE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 52 EUROPE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 53 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 54 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 55 EUROPE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 56 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
Table 57 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
Table 58 EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 59 GERMANY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 60 GERMANY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 61 GERMANY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 62 GERMANY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 63 GERMANY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 64 GERMANY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION
Table 65 GERMANY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 66 GERMANY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 67 FRANCE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 68 FRANCE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 69 FRANCE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 70 FRANCE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 71 FRANCE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 72 FRANCE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 73 FRANCE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 74 FRANCE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 75 ITALY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 76 ITALY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 77 ITALY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 78 ITALY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 79 ITALY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 80 ITALY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 81 ITALY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 82 ITALY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
Table 83 UK TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 84 UK TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 85 UK TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 86 UK SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 87 UK LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 88 UK SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 89 UK TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 90 UK TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 91 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 92 SWITZERLAND TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 93 SWITZERLAND TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 94 SWITZERLAND SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 95 SWITZERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 96 SWITZERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 97 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 98 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 99 SPAIN TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 100 SPAIN TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 101 SPAIN TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 102 SPAIN SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 1 LIST OF APPROVED TOPICAL DRUGS
Table 2 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION)
Table 3 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 4 GLOBAL TDDF MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 5 GLOBAL LIQUID TDDF MARKET, BY PRODUCT TYPE, 2015– 2024(USD BILLION)
Table 6 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015– 2024 (USD BILLION)
Table 7 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015– 2024 (USD BILLION)
Table 8 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
Table 9 GLOBAL ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2014 – 2024 (USD BILLION)
Table 10 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
Table 11 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD BILLION)
Table 12 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY, 2015 – 2024 (USD BILLION)
Table 13 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION)
Table 14 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD BILLION)
Table 15 NORTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 16 NORTH AMERICA TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
Table 17 NORTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
Table 18 NORTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
Table 19 NORTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD BILLION)
Table 20 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
Table 21 NORTH AMERICA ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015– 2024 (USD BILLION)
Table 22 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD BILLION)
Table 23 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD BILLION)
Table 24 U.S. TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION)
Table 25 U.S. TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 26 U.S. TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 27 U.S.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 28 U.S.LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
Table 29 U.S.SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 30 U.S. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 31 U.S. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 32 CANADA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION)
Table 33 CANADA TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 34 CANADA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 35 CANADA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 36 CANADALIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
Table 37 CANADASOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 38 CANADA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 39 CANADA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 40 MEXICO TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION)
Table 41 MEXICO TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 42 MEXICO TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 43 MEXICOSEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 44 MEXICOLIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
Table 45 MEXICOSOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 46 MEXICO TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 47 MEXICO TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 48 EUROPE TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION)
Table 49 EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 50 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 51 EUROPE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 52 EUROPE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 53 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 54 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 55 EUROPE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 56 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
Table 57 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
Table 58 EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 59 GERMANY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 60 GERMANY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 61 GERMANY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 62 GERMANY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 63 GERMANY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 64 GERMANY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION
Table 65 GERMANY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 66 GERMANY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 67 FRANCE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 68 FRANCE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 69 FRANCE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 70 FRANCE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 71 FRANCE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 72 FRANCE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 73 FRANCE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 74 FRANCE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 75 ITALY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 76 ITALY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 77 ITALY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 78 ITALY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 79 ITALY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 80 ITALY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 81 ITALY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 82 ITALY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
Table 83 UK TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 84 UK TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 85 UK TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 86 UK SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 87 UK LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 88 UK SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 89 UK TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 90 UK TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 91 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 92 SWITZERLAND TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 93 SWITZERLAND TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 94 SWITZERLAND SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
Table 95 SWITZERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 96 SWITZERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
Table 97 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
Table 98 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
Table 99 SPAIN TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 100 SPAIN TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
Table 101 SPAIN TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
Table 102 SPAIN SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
LIST OF FIGURES
Figure 1 GLOBAL TOPICAL DRUG DELIVERYMARKET: SEGMENTATION
Figure 2 GLOBAL TOPICAL DRUG DELIVERY MARKET: GEOGRAHIC SCOPE
Figure 3 GLOBAL TOPICAL DRUG DELIVERYMARKET: DATA TRIANGULATION
Figure 4 GLOBAL TOPICAL DRUG DELIVERY MARKET: SNAPSHOT
Figure 5 GLOBAL TOPICAL DRUG DELIVERYMARKET: BOTTOM UP APPROACH
Figure 6 GLOBAL TOPICAL DRUG DELIVERYMARKET: TOP DOWN APPROACH
Figure 7 GLOBAL TOPICAL DRUG DELIVERYMARKET: INTERVIEWS BY REGION AND DESIGNATION
Figure 8 TECHNOLOGICAL DEVELOPMENT AND INCREASING APPLICATIONS FOR TRANSDERMAL DRUG DELIVERY IS EXPECTED TO DRIVE THE MARKET FOR TOPICAL DRUG DELIVERY DEVICES MARKET IN THE FORECAST PERIOD 2017 TO 2024
Figure 9 TOPICAL DRUG DELIVERY FORMULATIONS MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL TOPICAL DRUG DELIVERY MARKET IN 2017 & 2024
Figure 10 APAC IS THE HIGHEST GROWING AND MOST PROFITable REVENUE POCKETS FOR TOPICAL DRUG DELIVERY MANUFACTURERS IN THE FORECAST PERIOD TO 2024
Figure 11 NORTH AMERICA IS EXPECTED TO BE DOMINATE THE MARKET FOR TOPICAL DRUG DELIVERY IN 2016 AND APAC IS EXPECTED TO GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD TO 2024
Figure 12 GLOBAL TOPICAL DRUG DELIVERY MARKET: BY TYPE, SNAPSHOT 2016
Figure 13 GLOBAL TOPICAL DRUG DELIVERY MARKET: BY INDICATION, SNAPSHOT 2016
Figure 14 GLOBAL TOPICAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
Figure 15 GLOBAL TOPICAL DRUG DELIVERYMARKET: BY END-USER, SNAPSHOT 2016
Figure 16 GLOBAL TOPICAL DRUG DELIVERY MARKET:BY GEOGRAPHY, 2016
Figure 17 GLOBAL TOPICAL DRUG DELIVERY PRESCRIPTION DRUGS MARKET: COMPANY SHARE 2016 (%)
Figure 1 GLOBAL TOPICAL DRUG DELIVERYMARKET: SEGMENTATION
Figure 2 GLOBAL TOPICAL DRUG DELIVERY MARKET: GEOGRAHIC SCOPE
Figure 3 GLOBAL TOPICAL DRUG DELIVERYMARKET: DATA TRIANGULATION
Figure 4 GLOBAL TOPICAL DRUG DELIVERY MARKET: SNAPSHOT
Figure 5 GLOBAL TOPICAL DRUG DELIVERYMARKET: BOTTOM UP APPROACH
Figure 6 GLOBAL TOPICAL DRUG DELIVERYMARKET: TOP DOWN APPROACH
Figure 7 GLOBAL TOPICAL DRUG DELIVERYMARKET: INTERVIEWS BY REGION AND DESIGNATION
Figure 8 TECHNOLOGICAL DEVELOPMENT AND INCREASING APPLICATIONS FOR TRANSDERMAL DRUG DELIVERY IS EXPECTED TO DRIVE THE MARKET FOR TOPICAL DRUG DELIVERY DEVICES MARKET IN THE FORECAST PERIOD 2017 TO 2024
Figure 9 TOPICAL DRUG DELIVERY FORMULATIONS MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL TOPICAL DRUG DELIVERY MARKET IN 2017 & 2024
Figure 10 APAC IS THE HIGHEST GROWING AND MOST PROFITable REVENUE POCKETS FOR TOPICAL DRUG DELIVERY MANUFACTURERS IN THE FORECAST PERIOD TO 2024
Figure 11 NORTH AMERICA IS EXPECTED TO BE DOMINATE THE MARKET FOR TOPICAL DRUG DELIVERY IN 2016 AND APAC IS EXPECTED TO GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD TO 2024
Figure 12 GLOBAL TOPICAL DRUG DELIVERY MARKET: BY TYPE, SNAPSHOT 2016
Figure 13 GLOBAL TOPICAL DRUG DELIVERY MARKET: BY INDICATION, SNAPSHOT 2016
Figure 14 GLOBAL TOPICAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
Figure 15 GLOBAL TOPICAL DRUG DELIVERYMARKET: BY END-USER, SNAPSHOT 2016
Figure 16 GLOBAL TOPICAL DRUG DELIVERY MARKET:BY GEOGRAPHY, 2016
Figure 17 GLOBAL TOPICAL DRUG DELIVERY PRESCRIPTION DRUGS MARKET: COMPANY SHARE 2016 (%)
